MDR-001
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)
MindRank AI Ltd · Phase 3 · Not yet recruiting · Enrollment 738
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| MDR-001 Dose 1 | n/r | n/r | n/r | n/r |
| MDR-001 Dose 2 | n/r | n/r | n/r | n/r |
| placebo | n/r | n/r | n/r | n/r |
Not shown
- MDR-001 Dose 1: endpoint not reported
- MDR-001 Dose 2: endpoint not reported
- placebo: endpoint not reported